HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of NADPH oxidase activation in oligodendrocytes reduces cytotoxicity following trauma.

Abstract
Spinal cord injury is a debilitating neurological disorder that initiates a cascade of cellular events that result in a period of secondary damage that can last for months after the initial trauma. The ensuing outcome of these prolonged cellular perturbations is the induction of neuronal and glial cell death through excitotoxic mechanisms and subsequent free radical production. We have previously shown that astrocytes can directly induce oligodendrocyte death following trauma, but the mechanisms regulating this process within the oligodendrocyte remain unclear. Here we provide evidence demonstrating that astrocytes directly regulate oligodendrocyte death after trauma by inducing activation of NADPH oxidase within oligodendrocytes. Spinal cord injury resulted in a significant increase in oxidative damage which correlated with elevated expression of the gp91 phox subunit of the NADPH oxidase enzyme. Immunohistochemical analysis confirmed the presence of gp91 phox in oligodendrocytes in vitro and at 1 week following spinal cord injury. Exposure of oligodendrocytes to media from injured astrocytes resulted in an increase in oligodendrocyte NADPH oxidase activity. Inhibition of NADPH oxidase activation was sufficient to attenuate oligodendrocyte death in vitro and at 1 week following spinal cord injury, suggesting that excitotoxicity of oligodendrocytes after trauma is dependent on the intrinsic activation of the NADPH oxidase enzyme. Acute administration of the NADPH oxidase inhibitor apocynin and the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate channel blocker 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione significantly improved locomotor behavior and preserved descending axon fibers following spinal cord injury. These studies lead to a better understanding of oligodendrocyte death after trauma and identify potential therapeutic targets in disorders involving demyelination and oligodendrocyte death.
AuthorsJoshua T Johnstone, Paul D Morton, Arumugam R Jayakumar, Andrea L Johnstone, Han Gao, Valerie Bracchi-Ricard, Damien D Pearse, Michael D Norenberg, John R Bethea
JournalPloS one (PLoS One) Vol. 8 Issue 11 Pg. e80975 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID24260524 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Acetophenones
  • Culture Media, Conditioned
  • Enzyme Inhibitors
  • Excitatory Amino Acid Antagonists
  • Membrane Glycoproteins
  • Quinoxalines
  • Receptors, AMPA
  • 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
  • acetovanillone
  • Cybb protein, mouse
  • NADPH Oxidase 2
  • NADPH Oxidases
Topics
  • Acetophenones (pharmacology)
  • Animals
  • Animals, Newborn
  • Astrocytes (metabolism, pathology)
  • Axons (metabolism, pathology)
  • Cell Death (drug effects)
  • Culture Media, Conditioned (pharmacology)
  • Enzyme Activation
  • Enzyme Inhibitors (pharmacology)
  • Excitatory Amino Acid Antagonists (pharmacology)
  • Female
  • Locomotion (drug effects)
  • Membrane Glycoproteins (antagonists & inhibitors, metabolism)
  • Mice
  • NADPH Oxidase 2
  • NADPH Oxidases (antagonists & inhibitors, metabolism)
  • Oligodendroglia (cytology, drug effects, enzymology)
  • Oxidative Stress
  • Primary Cell Culture
  • Quinoxalines (pharmacology)
  • Receptors, AMPA (antagonists & inhibitors, metabolism)
  • Spinal Cord Injuries (drug therapy, enzymology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: